Depressing.
There are no clinically valid prediction models for recurrence/relapse of depression. I find this rather disappointing. https://t.co/CaxY5ZTTm4 https://t.co/nqsNc5hRTU
📰Prévision de la rechute ou de la récidive de la dépression https://t.co/UKZCfvnt5s
Predicting recurring depression and why this is so hard: 10/11 models show risk of bias; the one that doesn't predicts poorly (in effect, it does not predict) https://t.co/GfkX6V5DLy
The relapse model review: 10 of the 11 included studies were at high risk of bias. 1 paper was at low risk of bias & presented following predictors: N of previous depressive episodes, residual depressive symptoms & severity of the last depressive e
予測を見事に言い当てた、みたいなN=1の神業みたいなのはよく聞くけど、いつでもとなると、なかなか厳しいものよ。 Prognostic models for predicting relapse or recurrence of major depressive disorder in adults - Moriarty, AS - 2021 | Cochrane Library https://t.co/RVq71RoWtR
『うつ病の再燃・再発の予測』 https://t.co/4ci5JYZbuO #うつ病
RT @CochraneJapan: うつ病の再燃・再発の予測 https://t.co/41KjNLINsS
RT @CochraneJapan: うつ病の再燃・再発の予測 https://t.co/41KjNLINsS
RT @CochraneJapan: うつ病の再燃・再発の予測 https://t.co/41KjNLINsS
明確な指標はないってことかな
うつ病の再燃・再発の予測 https://t.co/41KjNLINsS
うつ病の再燃・再発の予測 https://t.co/eVEXg4Ovus
Predicting relapse or recurrence of #depression - New prognostic review from @Cochrane_CCMD ➡️ Interview with lead authors: https://t.co/ReYUAY1vpN And full review: https://t.co/2WMy4GDkpj https://t.co/XmQJvP6hCP
RT @CochraneUK: New Review: Predicting relapse or recurrence of depression https://t.co/X3lWKjrjaR Find out more in this @Cochrane_CCMD int…
RT @CochraneUK: New Review: Predicting relapse or recurrence of depression https://t.co/X3lWKjrjaR Find out more in this @Cochrane_CCMD int…
RT @CochraneUK: New Review: Predicting relapse or recurrence of depression https://t.co/X3lWKjrjaR Find out more in this @Cochrane_CCMD int…
RT @CochraneColomb: Predicción de la recaída o recurrencia de la #depresión: nueva revisión de pronóstico de @Cochrane_CCMD ➡️ Entrevista c…
Predicción de la recaída o recurrencia de la #depresión: nueva revisión de pronóstico de @Cochrane_CCMD ➡️ Entrevista con los autores principales (En inglés): https://t.co/NBpBLSoWZv Y Acceso a revisión completa: https://t.co/WLpISODQXB
RT @cochranecollab: Methods to help identify which people are more likely to experience relapse or recurrence of #depression - New prognost…
Methods to help identify which people are more likely to experience relapse or recurrence of #depression - New prognostic review from @Cochrane_CCMD https://t.co/kOvSJDN3pQ https://t.co/V6yawLS15x
RT @Cochrane_CCMD: New Review: Predicting relapse or recurrence of depression https://t.co/4xneAXqhv5 Find out more in this @cochranecollab…
RT @cochrane_nz: Prognostic models for predicting relapse or recurrence of major depressive disorder in adults. Accurate prediction may im…
RT @cochranecollab: Predicting relapse or recurrence of #depression - New prognostic review from @Cochrane_CCMD ➡️ Interview with lead auth…
Prognostic models for predicting relapse or recurrence of major depressive disorder in adults. Accurate prediction may improve outcomes for patients by enabling more efficient allocation of interventions. Read the Cochrane Review here: https://t.co/J5IuYG
RT @cochranecollab: Predicting relapse or recurrence of #depression - New prognostic review from @Cochrane_CCMD ➡️ Interview with lead auth…
RT @cochranecollab: Predicting relapse or recurrence of #depression - New prognostic review from @Cochrane_CCMD ➡️ Interview with lead auth…
Predicting relapse or recurrence of #depression - New prognostic review from @Cochrane_CCMD ➡️ Interview with lead authors: https://t.co/vvrqY3YZkd And full review: https://t.co/kOvSJDN3pQ https://t.co/hXLNbrq9Y3
RT @Cochrane_CCMD: New Review: Predicting relapse or recurrence of depression https://t.co/4xneAXqhv5 Find out more in this @cochranecollab…
RT @Cochrane_CCMD: New Review: Predicting relapse or recurrence of depression https://t.co/4xneAXqhv5 Find out more in this @cochranecollab…
RT @Cochrane_CCMD: New Review: Predicting relapse or recurrence of depression https://t.co/4xneAXqhv5 Find out more in this @cochranecollab…
New Review: Predicting relapse or recurrence of depression https://t.co/4xneAXqhv5 Find out more in this @cochranecollab interview with two of the authors (@A_S_Moriarty from @MHARG_york and @crd_york Nick Meader)⬇️ https://t.co/yj8ALSkxlb https://t.co/4D3
RT @CochraneLibrary: Predicting relapse or recurrence of #depression - New prognostic review from @Cochrane_CCMD ➡️ Interview with lead aut…
RT @CochraneLibrary: Predicting relapse or recurrence of #depression - New prognostic review from @Cochrane_CCMD ➡️ Interview with lead aut…
Predicting relapse or recurrence of #depression - New prognostic review from @Cochrane_CCMD ➡️ Interview with lead authors: https://t.co/aEmd2sepxY And full review: https://t.co/HQQtQ0BdwI https://t.co/aaMm1WT9Ge
RT @A_S_Moriarty: @InvolvementYork have been invaluable in supporting the #PPIE input into this review and other aspects of our ongoing pro…
RT @A_S_Moriarty: @InvolvementYork have been invaluable in supporting the #PPIE input into this review and other aspects of our ongoing pro…
RT @A_S_Moriarty: @InvolvementYork have been invaluable in supporting the #PPIE input into this review and other aspects of our ongoing pro…
RT @A_S_Moriarty: @InvolvementYork have been invaluable in supporting the #PPIE input into this review and other aspects of our ongoing pro…
RT @Cochrane_CCMD: New Review: Predicting relapse or recurrence of depression @CochraneLibrary https://t.co/4xneAXqhv5 📰Find out more in th…
RT @CochraneLibrary: Methods to help identify which people are more likely to experience relapse or recurrence of #depression - New prognos…
RT @Cochrane_CCMD: 📢New #CochraneReview published from @A_S_Moriarty & colleagues from @MHARG_york @crd_york @Keele_MHRes @HullYorkMed - Ev…
RT @CochraneLibrary: Methods to help identify which people are more likely to experience relapse or recurrence of #depression - New prognos…
Methods to help identify which people are more likely to experience relapse or recurrence of #depression - New prognostic review from @Cochrane_CCMD https://t.co/HQQtQ0BdwI https://t.co/tXJeXdT8Bz
"At present, existing models are unlikely to reliably predict an individual’s risk. There is a need for better quality prognostic model studies for relapse and recurrence of #depression."
RT @A_S_Moriarty: Worked with a brilliant group of colleagues on this. Thanks to @SimonGilbody @CizCG @Kym_Snell @Richard_D_Riley @drbobphi…
RT @A_S_Moriarty: Worked with a brilliant group of colleagues on this. Thanks to @SimonGilbody @CizCG @Kym_Snell @Richard_D_Riley @drbobphi…
RT @A_S_Moriarty: Worked with a brilliant group of colleagues on this. Thanks to @SimonGilbody @CizCG @Kym_Snell @Richard_D_Riley @drbobphi…
RT @A_S_Moriarty: Worked with a brilliant group of colleagues on this. Thanks to @SimonGilbody @CizCG @Kym_Snell @Richard_D_Riley @drbobphi…
@InvolvementYork have been invaluable in supporting the #PPIE input into this review and other aspects of our ongoing project 🙏 @HealthSciYork @MHARG_york
RT @A_S_Moriarty: Worked with a brilliant group of colleagues on this. Thanks to @SimonGilbody @CizCG @Kym_Snell @Richard_D_Riley @drbobphi…
RT @Cochrane_CCMD: New Review: Predicting relapse or recurrence of depression @CochraneLibrary https://t.co/4xneAXqhv5 📰Find out more in th…
RT @Cochrane_CCMD: 📢New #CochraneReview published from @A_S_Moriarty & colleagues from @MHARG_york @crd_york @Keele_MHRes @HullYorkMed - Ev…
RT @A_S_Moriarty: Worked with a brilliant group of colleagues on this. Thanks to @SimonGilbody @CizCG @Kym_Snell @Richard_D_Riley @drbobphi…
Worked with a brilliant group of colleagues on this. Thanks to @SimonGilbody @CizCG @Kym_Snell @Richard_D_Riley @drbobphillips @ChurchillRachel @Cochrane_CCMD @MHARG_york @HYMS_APC @SoM_Research Cochrane Prognosis Methods Group & team #PPIE (+ those no
RT @Cochrane_CCMD: Delighted @A_S_Moriarty & coauthors (including @Richard_D_Riley) have just published our 1⃣st💫Prognostic Models💫#Cochran…
RT @Cochrane_CCMD: New Review: Predicting relapse or recurrence of depression @CochraneLibrary https://t.co/4xneAXqhv5 📰Find out more in th…
New Review: Predicting relapse or recurrence of depression @CochraneLibrary https://t.co/4xneAXqhv5 📰Find out more in this @cochranecollab interview with two of the authors (@A_S_Moriarty from @MHARG_york and @crd_york Nick Meader)⬇️ https://t.co/yj8ALSkxl
RT @Cochrane_CCMD: 📢New #CochraneReview published from @A_S_Moriarty & colleagues from @MHARG_york @crd_york @Keele_MHRes @HullYorkMed - Ev…
RT @Cochrane_CCMD: 📢New #CochraneReview published from @A_S_Moriarty & colleagues from @MHARG_york @crd_york @Keele_MHRes @HullYorkMed - Ev…
.@SimonGilbody .@A_S_Moriarty .@Richard_D_Riley .@SoM_Research
RT @Cochrane_CCMD: New review published today -@UniOfYork news story highlighting research to identify adults at increased risk of relapse…
RT @Cochrane_CCMD: 📢New #CochraneReview published from @A_S_Moriarty & colleagues from @MHARG_york @crd_york @Keele_MHRes @HullYorkMed - Ev…
RT @Cochrane_CCMD: Delighted @A_S_Moriarty & coauthors (including @Richard_D_Riley) have just published our 1⃣st💫Prognostic Models💫#Cochran…
RT @Cochrane_CCMD: Delighted @A_S_Moriarty & coauthors (including @Richard_D_Riley) have just published our 1⃣st💫Prognostic Models💫#Cochran…
RT @Cochrane_CCMD: 📢New #CochraneReview published from @A_S_Moriarty & colleagues from @MHARG_york @crd_york @Keele_MHRes @HullYorkMed - Ev…
RT @Cochrane_CCMD: 📢New #CochraneReview published from @A_S_Moriarty & colleagues from @MHARG_york @crd_york @Keele_MHRes @HullYorkMed - Ev…
RT @SimonGilbody: really important review from our own #PhDNinja & #GPLegend @A_S_Moriarty. this is the first prognostic review for the @C…
RT @SimonGilbody: really important review from our own #PhDNinja & #GPLegend @A_S_Moriarty. this is the first prognostic review for the @C…
RT @Cochrane_CCMD: 📢New #CochraneReview published from @A_S_Moriarty & colleagues from @MHARG_york @crd_york @Keele_MHRes @HullYorkMed - Ev…
RT @Cochrane_CCMD: 📢New #CochraneReview published from @A_S_Moriarty & colleagues from @MHARG_york @crd_york @Keele_MHRes @HullYorkMed - Ev…
RT @Cochrane_CCMD: Delighted @A_S_Moriarty & coauthors (including @Richard_D_Riley) have just published our 1⃣st💫Prognostic Models💫#Cochran…
RT @SimonGilbody: really important review from our own #PhDNinja & #GPLegend @A_S_Moriarty. this is the first prognostic review for the @C…
Delighted @A_S_Moriarty & coauthors (including @Richard_D_Riley) have just published our 1⃣st💫Prognostic Models💫#CochraneReview https://t.co/4xneAXqhv5. Big thanks to Anneke Damen & the Cochrane Prognosis Methods Group @cochranemthds for all the he
RT @Cochrane_CCMD: New review published today -@UniOfYork news story highlighting research to identify adults at increased risk of relapse…
really important review from our own #PhDNinja & #GPLegend @A_S_Moriarty. this is the first prognostic review for the @Cochrane_CCMD, and we look at how we can predict relapse for people with depression; esp in primary care....
RT @Cochrane_CCMD: 📢New #CochraneReview published from @A_S_Moriarty & colleagues from @MHARG_york @crd_york @Keele_MHRes @HullYorkMed - Ev…
.@SoM_Research .@KeeleUniversity
RT @Cochrane_CCMD: New review published today -@UniOfYork news story highlighting research to identify adults at increased risk of relapse…
New review published today -@UniOfYork news story highlighting research to identify adults at increased risk of relapse and recurrence of depression essential⬇️ Read @MHARG_york @KeeleUniversity @HullYorkMed review @CochraneLibrary https://t.co/4xneAXqhv5
📢New #CochraneReview published from @A_S_Moriarty & colleagues from @MHARG_york @crd_york @Keele_MHRes @HullYorkMed - Evidence about methods to help identify which people are more likely to experience relapse or recurrence of depression @CochraneLibrar